IL4 and Alzheimer disease: In a study involving DNCB-induced mice, topical application of this mixture reduced symptoms of AD, such as epidermal thickness and mast cell infiltration, and decreased the levels of proinflammatory cytokines like TNFα, IFNγ, and IL4, as well as serum IgE levels [76].